Navigation Links
Experimental vaccine protects monkeys against chikungunya
Date:3/4/2010

GALVESTON, Texas Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or treatment exists to protect humans from its effects.

The scenario may sound like something dreamed up as a training exercise by public health authorities, but the virus is all too real. Called chikungunya, from an East African tribal word describing the contorted postures of its pain-wracked victims, the pathogen has been the focus of intense scientific interest ever since a 2006 outbreak on the island of La Reunion in the Indian Ocean infected about 266,000 people, killing 260 of them.

Now, researchers at the National Institute of Allergy and Infectious Diseases, the University of Texas Medical Branch at Galveston, Purdue University and Bioqual Inc. have developed an experimental vaccine for chikungunya virus and successfully tested it in monkeys. Described in a paper appearing in the March issue of Nature Medicine, the vaccine is composed of noninfectious "virus-like particles." Although coated with the same proteins that enable chikungunya to pass through cell membranes, the vaccine particles lack the proteins that chikungunya uses to replicate inside cells. They look like chikungunya to the immune systems of rhesus macaques, however, which respond to exposure by generating antibodies that defend the monkeys from infection by the real virus.

"This vaccine did an excellent job of protecting the macaques from chikungunya," said UTMB professor Stephen Higgs, one of the paper's authors. "That it worked so well in a primate model is good news these macaques are quite similar to humans in their response to c
'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2

Related biology news :

1. Experimental drug shows promise against brain, prostate cancers
2. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009
3. Experimental treatments restore partial vision to blind people
4. Experimental treatment halts hypoxic-ischemic brain injury in newborns
5. 40 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans
6. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
7. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize
8. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
9. Experimental Biology and Medicine announces expansion into Asia, opens new office
10. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
11. Experimental Biology 2008 meets in San Diego April 5-9
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 15, 2015  BellBrook Labs, a leader in high ... launch of a TR-FRET (time resolved Forster resonance ... Assay, a high throughput screening assay for glycosyltransferases ... allow for sensitive detection of hundreds of human ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small Cap ... report showed that planet-wide, transactions at merchants on the leading ... total number of credit, debit, and prepaid cards reached 6.54 ... victims of fraudulent card usage in 2012, and credit and ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... 2012) When different types of cells are transplanted ... central nervous system (CNS) trauma, what is the fate ... carried out research aimed at answering this question by ... cells, mouse embryonic fibroblasts, dendritic cells, bone marrow mononuclear ...
... been recognized for creating technologies or processes that can ... fight cancer and detect explosives, and then moving the ... announced today that the Department of Energy national laboratory ... Transfer awards. The consortium is a nationwide network ...
... (WCS) lauded U.S. Secretary of the Interior Ken Salazars ... Petroleum Reserve-Alaska (NPR-A) that balances wildlife conservation and energy ... The Integrated Activity Plan and Final Environmental Impact ... Land Management is the first comprehensive land management plan ...
Cached Biology News:Cell Transplantation study investigates fate and function of cells transplanted to the CNS 2PNNL recognized for transferring innovations to the marketplace 2PNNL recognized for transferring innovations to the marketplace 3WCS applauds Dept. of Interior plan balancing conservation and energy development in NPR-A 2
(Date:3/3/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Personalized Medicine - Scientific ... , The aim of personalized medicine ... drug to the right patient and, in some ... a patient according to his/her genotype. This report ...
(Date:3/3/2015)... , March 3, 2015 ... with tools for implementing competency-based training to comply with ... DirectCourse is offering a new crosswalk tool ... (HCBS) implement competency-based training for direct service workers as ... & Medicaid Services (CMS) regulations. CMS amended ...
(Date:3/3/2015)... , March 3, 2015  PDL BioPharma, Inc. (PDL ... announced that the third of three shareholder lawsuits filed ... prejudice. On February 2, 2015, a securities ... on behalf of a putative class of purchasers of ... al., No. 2:14-CV-01526-APG-NJK (D. Nev.), was voluntarily dismissed without ...
(Date:3/2/2015)... March 02, 2015 Shimadzu Scientific Instruments ... present on LCMS and marijuana analysis at the Pittcon ... 8 to 12 at the Ernest N. Morial Convention ... stop by booth 3121 to discuss laboratory challenges with ... innovative, proven products help save time, money and effort ...
Breaking Biology Technology:Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3
... (OTC Bulletin Board: CCEL) (the "Company"), one of ... banks, today,announced results for the second quarter and ... revenues for the second quarter were approximately $4.5,million, ... for the second quarter of 2007. The Company ...
... Guidance: (greater than or equal,to)12%, EUR millions 2006 ... EURM %Sales EURM %Sales % EURM %Sales ... change ... 13 26.8 71 15 Other EU countries (2) 6.9 24 7.7 ...
... /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology,International, Inc. ("Yongye" or ... distributor of plant and animal nutrients headquartered ... MSPC Certified Public,Accountants and Advisors, P.C. as ... has engaged MSPC Certified Public Accountants and ...
Cached Biology Technology:Cryo-Cell International, Inc. Reports Second Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Second Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Second Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Second Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Second Quarter 2008 Results 6Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth 2Yongye Biotechnology International, Inc. Appoints New Independent Auditor 2
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Use the DUALmembrane kit 3 to carry out DUALmembrane interaction analysis and cDNA library screening to characterize interactions between integral membrane proteins and to identify novel interaction ...
... effectively seals labware. Waterproof, moisture-proof film ... materials. Can be folded repeatedly and ... Stretched lengthwise at 21C (70F), wrapping ... tension is removed, film only partially ...
Biology Products: